Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Idiopathic Pulmonary Fibrosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Class
1.4.3 Oxygen Therapy
1.4.4 Lung Transplant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Idiopathic Pulmonary Fibrosis Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Idiopathic Pulmonary Fibrosis Treatment Market Size
2.2 Idiopathic Pulmonary Fibrosis Treatment Growth Trends by Regions
2.2.1 Idiopathic Pulmonary Fibrosis Treatment Market Size by Regions (2019-2025)
2.2.2 Idiopathic Pulmonary Fibrosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Idiopathic Pulmonary Fibrosis Treatment Market Size by by Players
3.1.1 Global Idiopathic Pulmonary Fibrosis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Idiopathic Pulmonary Fibrosis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Idiopathic Pulmonary Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Idiopathic Pulmonary Fibrosis Treatment Key Players Head office and Area Served
3.3 Key Players Idiopathic Pulmonary Fibrosis Treatment Product/Solution/Service
3.4 Date of Enter into Idiopathic Pulmonary Fibrosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Type (2014-2019)
4.2 Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
5.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in North America
5.3 North America Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
5.4 North America Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
6 Europe
6.1 Europe Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
6.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in Europe
6.3 Europe Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
6.4 Europe Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
7 China
7.1 China Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
7.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in China
7.3 China Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
7.4 China Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
8 Japan
8.1 Japan Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
8.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in Japan
8.3 Japan Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
8.4 Japan Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
9.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
9.4 Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
10 India
10.1 India Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
10.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in India
10.3 India Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
10.4 India Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size (2014-2019)
11.2 Idiopathic Pulmonary Fibrosis Treatment Key Players in Central & South America
11.3 Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size by Type
11.4 Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size by Application
12 International Players Profiles
12.1 Biogen
12.1.1 Biogen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.1.4 Biogen Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019))
12.1.5 Biogen Recent Development
12.2 Boehringer Ingelheim GMBH
12.2.1 Boehringer Ingelheim GMBH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.2.4 Boehringer Ingelheim GMBH Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.2.5 Boehringer Ingelheim GMBH Recent Development
12.3 Bristol-Myers Squibb Company
12.3.1 Bristol-Myers Squibb Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.3.4 Bristol-Myers Squibb Company Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.3.5 Bristol-Myers Squibb Company Recent Development
12.4 Cipla
12.4.1 Cipla Company Details
12.4.2 Company Description and Business Overview
12.4.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.4.4 Cipla Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.4.5 Cipla Recent Development
12.5 Hoffmann-La Roche AG
12.5.1 Hoffmann-La Roche AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.5.4 Hoffmann-La Roche AG Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.5.5 Hoffmann-La Roche AG Recent Development
12.6 Fibrogen, Inc.
12.6.1 Fibrogen, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.6.4 Fibrogen, Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.6.5 Fibrogen, Inc. Recent Development
12.7 Galapagos NV
12.7.1 Galapagos NV Company Details
12.7.2 Company Description and Business Overview
12.7.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.7.4 Galapagos NV Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.7.5 Galapagos NV Recent Development
12.8 Medicinova, Inc.
12.8.1 Medicinova, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.8.4 Medicinova, Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.8.5 Medicinova, Inc. Recent Development
12.9 Merck & Co., Inc.
12.9.1 Merck & Co., Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.9.4 Merck & Co., Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.9.5 Merck & Co., Inc. Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Idiopathic Pulmonary Fibrosis Treatment Introduction
12.10.4 Novartis AG Revenue in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
12.10.5 Novartis AG Recent Development
12.11 Prometic Life Sciences Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Idiopathic Pulmonary Fibrosis Treatment Key Market Segments
Table Key Players Idiopathic Pulmonary Fibrosis Treatment Covered
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Class Figures
Table Key Players of Drug Class
Figuer Oxygen Therapy Figures
Table Key Players of Oxygen Therapy
Figuer Lung Transplant Figures
Table Key Players of Lung Transplant
Figuer Others Figures
Table Key Players of Others
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Idiopathic Pulmonary Fibrosis Treatment Report Years Considered
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Idiopathic Pulmonary Fibrosis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Share by by Players (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Share by by Players in 2018
Table Global Idiopathic Pulmonary Fibrosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Idiopathic Pulmonary Fibrosis Treatment Product/Solution/Service
Table Date of Enter into Idiopathic Pulmonary Fibrosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size Share by Type (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size Share by Application (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Revenue Market Share by Application in 2018
Figure North America Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table North America Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table North America Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure Europe Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table Europe Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table Europe Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure China Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table China Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table China Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure Japan Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table Japan Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table Japan Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure India Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table India Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table India Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Figure Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Idiopathic Pulmonary Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Idiopathic Pulmonary Fibrosis Treatment Market Share (2018-2019)
Table Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Share by Type 2014-2019
Table Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Share by Application 2014-2019
Table Biogen Company Details
Table Biogen Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Biogen Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Biogen Recent Development
Table Boehringer Ingelheim GMBH Company Details
Table Boehringer Ingelheim GMBH Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim GMBH Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Boehringer Ingelheim GMBH Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Cipla Company Details
Table Cipla Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Cipla Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Cipla Recent Development
Table Hoffmann-La Roche AG Company Details
Table Hoffmann-La Roche AG Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Hoffmann-La Roche AG Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Hoffmann-La Roche AG Recent Development
Table Fibrogen, Inc. Company Details
Table Fibrogen, Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Fibrogen, Inc. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Fibrogen, Inc. Recent Development
Table Galapagos NV Company Details
Table Galapagos NV Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Galapagos NV Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Galapagos NV Recent Development
Table Medicinova, Inc. Company Details
Table Medicinova, Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Medicinova, Inc. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Medicinova, Inc. Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Idiopathic Pulmonary Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Idiopathic Pulmonary Fibrosis Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Prometic Life Sciences Inc. Company Details
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size Share by Regions in 2025
Figure North America Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Idiopathic Pulmonary Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Product (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Product in 2025
Table Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Application (2019-2025)
Figure Global Idiopathic Pulmonary Fibrosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
Biogen、Boehringer Ingelheim GMBH、Bristol-Myers Squibb Company、Cipla、Hoffmann-La Roche AG、Fibrogen, Inc.、Galapagos NV、Medicinova, Inc.、Merck & Co., Inc.、Novartis AG、Prometic Life Sciences Inc.
